The GELATI Trial

Ho, K.M. and Smart, L.ORCID: 0000-0003-4776-2849 (2017) The GELATI Trial. In: 19th Annual Meeting on Clinical Trials in Intensive Care (ANZICS) 2017, March 2017, Noosa, QLD, Australia.

Abstract

Synthetic colloid fluids are frequently used for blood volume expansion in critically ill patients. Starch-based synthetic colloid fluids have been associated with increased risk of acute kidney injury. There is some evidence that gelatine-based colloid fluids may also pose a similar risk. This randomised open-label controlled pilot trial will assess the effects of 4% succinylated gelatine fluid on urinary biomarkers of acute kidney injury in Intensive Care Unit (ICU) patients. This study will also assess clinical outcomes, as secondary endpoints, including change in AKI stage, need for renal replacement therapy (RRT), ICU length of stay and mortality.

Item Type:	Conference Item
Murdoch Affiliation(s):	School of Veterinary and Life Sciences
Conference Website:	https://www.anzics.com.au/
URI:	http://researchrepository.murdoch.edu.au/id/eprint/55645

Item Control Page